G

Geneoscopy

59 employees

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
RNA Biomarkers
Noninvasive Diagnostic Screening
GI Health
Health Diagnostics
seRNA
IBD
Health Care
Colorectal Cancer Screening
GI Disease Companion Diagnostics
Life Sciences
Precision Medicine Partnerships
Genetics

Date founded

2015

Funding rounds raised

Total raised

$105M

from 7 investors over 7 rounds

G

Geneoscopy raised $105M on November 16, 2021

Investors: Labcorp, Innovatus Capital Partners and Morningside Venture Capital 晨兴资本

G

Geneoscopy raised $6.9M on October 2, 2019

Investors: Cultivation Capital

G

Geneoscopy raised $1M on April 13, 2018

Investors: Missouri Technology Corporation

G

Geneoscopy raised undisclosed on October 1, 2016

Investors: Dorm Room Fund and Arch Grants

FAQ